Novartis reported 5.08B in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Alcon AG ALC:SW 854M 49M
Amgen AMGN:US $ 1403M 37M
Bayer BAYN:GR 5.85B 945M
Biogen BIIB:US $ 398.7M 190.5M
Bristol Myers Squibb BMY:US $ 2944M 5M
Eli Lilly And LLY:US $ 1433.3M 237.3M
Fresenius FRE:GR € 1897M 142M
Fresenius Medical Care FME:GR € 790.24M 54.17M
Galapagos GLPG:NA 134.67M 2.75M
Gilead Sciences GILD:US $ 583M 122M
H. Lundbeck A/S LUN:DC 4.14B 224M
Hikma Pharmaceutical HIK:LN 262M 36M
Johnson & Johnson JNJ:US $ 9309M 1746M
Merck MRK:GR € 2356M 24M
Merk MRK:US $ 3715M 894M
Novartis NOVN:VX 5.08B 470M
Novartis NVS:US $ 5083M 470M
Orion ORNBV:FH 67.4M 22.2M
Pfizer PFE:US $ 5506M 72M
Recordati REC:IM 195M 17.07M
Regeneron Pharmaceuticals REGN:US $ 470.3M 93.7M